122
Participants
Start Date
October 26, 2020
Primary Completion Date
April 30, 2027
Study Completion Date
April 30, 2030
Avelumab
Avelumab IV infusion
Placebo
Placebo IV infusion
Chris O'Brien Lifehouse, Sydney
Melanoma Institute Australia, Sydney
Royal North Shore Hospital, Sydney
Westmead Hospital, Sydney
Calvary Mater Hospital, Sydney
Port Macquarie Base Hospital, Port Macquarie
Cancer Care Wollongong, Wollongong
Alfred Hospital, Melbourne
Peter MacCallum Cancer Centre, Melbourne
Royal Brisbane and Woman's Hospital, Brisbane
Princess Alexandra Hospital, Woolloongabba
Tasman Health Care, Southport
Cancer Care Service, Hervey Bay Hospital, Hervey Bay
Cancer Care Service, Bundaberg Base Hospital, Bundaberg
Mackay Hospital and Health Service, Mackay
Cairns Hospital, Cairns
Royal Adelaide Hospital, Adelaide
Icon Cancer Centre Hobart, Hobart
Townsville Hospital, Townsville
Auckland City Hospital, Auckland
Melanoma and Skin Cancer Trials Limited
OTHER